Status:

COMPLETED

Customized Approaches for Evaluating and Reducing Chemical Exposures From Home Building Materials

Lead Sponsor:

Duke University

Conditions:

Environmental Exposure

Eligibility:

FEMALE

Phase:

NA

Brief Summary

This project will evaluate new approaches to quantify and reduce chemical exposures from common building materials, with an emphasis on plastic additives, pesticides, flame retardants and lead in addi...

Detailed Description

This study will leverage Project HOPE 1000 (Duke University Health System IRB Pro00100000), an existing longitudinal pregnancy cohort study. Investigators will invite a subset of women participating i...

Eligibility Criteria

Inclusion

  • Participants enrolled in Project HOPE 1000, a pregnancy cohort study at Duke University Medical Center.
  • Any enrolled HOPE 1000 participants planning to remain in their homes for at least the following 12 weeks will be eligible for our sub-studies.

Exclusion

  • Individuals not planning to remain in their homes for at least 12 weeks.
  • Those not able to communicate in fluent English will be excluded.

Key Trial Info

Start Date :

August 11 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 11 2024

Estimated Enrollment :

75 Patients enrolled

Trial Details

Trial ID

NCT05416281

Start Date

August 11 2022

End Date

October 11 2024

Last Update

November 18 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Duke University

Durham, North Carolina, United States, 27708